VTRS Announces CEO NAME_1 Resignation Effective Immediately, Appoints NAME_2 as New CEO, 2024 Revenue $1.2B, EPS $0.45, 15% YoY Growth
Viatris Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $16.26
+14% in 3d after detection
Post-detection moves
1h
—
1d
+2.1%
3d
+14%
7d
+14%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS